The Polyphenolic Profile and Antioxidant Activity of Five Vegetal Extracts with Hepatoprotective Potential

Oxidative stress is among the major triggers for many important human functional disorders, which often lead to various metabolic or tissue diseases. The aim of the study is to obtain five standardized vegetal extracts (Cynarae extractum-CE, Rosmarini extractum-RE, Taraxaci extractum-TE, Cichorii extractum-CHE, and Agrimoniae extractum-AE) that contain active principles with an essential role in protecting liver cells against free radicals and quantify their antioxidant actions. The compounds of therapeutic interest from the analyzed extracts were identified and quantified using the UHPLC-HRMS/MS technique. Thus, the resulting identified compounds were 28 compounds in CE, 48 compounds in RE, 39 compounds in TE, 43 compounds in CHE, and 31 compounds in AE. These compounds belong to the class of flavonoids, isoflavones, phenolic acids and dicarboxylic acids, depsides, diterpenes, triterpenes, sesquiterpenes, proanthocyanidins, or coumarin derivatives. From the major polyphenolic compounds quantified in all the extracts analyzed by UHPLC-HRMS/MS, considerable amounts have been found for chlorogenic acid (619.8 mu g/g extract for TE-2032.4 mu g/g extract for AE), rutoside (105.1 mu g/g extract for RE-1724.7 mu g/g extract for AE), kaempferol (243 mu g/g extract for CHE-2028.4 mu g/g extract for CE), and for naringenin (383 mu g/g extract for CHE-1375.8 mu g/g extract for AE). The quantitative chemical analysis showed the highest content of total phenolic acids for AE (24.1528 +/- 1.1936 g chlorogenic acid/100 g dry extract), the highest concentration of flavones for RE (6.0847 +/- 0.3025 g rutoside/100 g dry extract), and the richest extract in total polyphenols with 31.7017 +/- 1.2211 g tannic acid equivalent/100 g dry extract for AE. Several methods (DPPH, ABTS, and FRAP) have been used to determine the in vitro total antioxidant activity of the extracts to evaluate their free radical scavenging ability, influenced by the identified compounds. As a result, the correlation between the content of the polyphenolic compounds and the antioxidant effect of the extracts has been demonstrated. Statistically significant differences were found when comparing the antiradical capacity within the study groups. Although all the analyzed extracts showed good IC50 values, which may explain their antihepatotoxic effects, the highest antioxidant activity was obtained for Agrimoniae extractum (IC50(ABTS) = 0.0147 mg/mL) and the lowest antioxidant activity was obtained for Cynarae extractum (IC50(ABTS) = 0.1588 mg/mL). Furthermore, the hepatoprotective potential was evaluated in silico by predicting the interactions between the determined phytochemicals and key molecular targets relevant to liver disease pathophysiology. Finally, the evaluation of the pharmacognostic and phytochemical properties of the studied extracts validates their use as adjuvants in phytotherapy, as they reduce oxidative stress and toxin accumulation and thus exert a hepatoprotective effect at the cellular level.

Automated summary

Oxidative stress is a major factor in human functional disorders, and this study aimed to obtain standardized plant extracts containing active compounds that protect liver cells against free radicals. The extracts were analyzed to identify and quantify therapeutic compounds using UHPLC-HRMS/MS. The extracts contained various flavonoids, phenolic acids, and polyphenols. In vitro experiments confirmed the extracts' antioxidant activity, and a correlation was found between the content of polyphenolic compounds and the antioxidant effect. The extracts also showed hepatoprotective potential in silico. This study validates the use of these extracts in phytotherapy due to their ability to reduce oxidative stress and protect liver cells.